The FDA has approved the Minima stent system, the first device specifically designed for infants and young children with congenital heart defects. The innovative stent could help thousands of children ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement that provides best-practice guidance for the treatment of patent ductus arteriosus (PDA) using ...

The FDA has approved a new type of stent designed specifically for infants and young children—including neonates born with congenital heart defects—that’s designed to expand in size as the child grows ...

The Food and Drug Administration recently approved a heart stent made specifically for infants and young children, a device that could help kids born with certain congenital heart defects avoid a ...

Dr. Ringewald notes this first-of-its-kind stent is far easier to advance and deploy compared with other stents due to its small size, which markedly diminishes procedural risk. "The Minima stent is a ...

MIAMI, Aug. 28, 2025 /PRNewswire/ -- Nicklaus Children's Hospital's Heart Institute is ushering in a new era of cardiac treatment for children across South Florida. Nicklaus Children's is the first ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...